Profound Medical signs co-education deal with Telix
Profound Medical said it entered a co-education agreement with Telix to promote PSMA-PET imaging and TULSA-PRO integration for prostate care.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Profound Medical and Telix sign co-education agreement
Profound Medical and Telix Pharmaceuticals announced a co-education agreement to train physicians and prostate cancer centers on PSMA-PET molecular imaging and MRI-guided TULSA-PRO.
Profound Medical and Telix sign co-education pact
The companies say the agreement is intended to educate physicians and prostate cancer centers on combining Telix PSMA-PET molecular imaging and Profound MRI-guided TULSA-PRO.